Clinomics Europe’s Post

To singleplex or multiplex, what’s the difference? These two detection methods for genomic analysis involve different assay design and setup, and each one has its own set of advantages and disadvantages. Take a look at what you should consider for your experiment: https://lnkd.in/gj56dBnR #genotyping #geneexpression #scienceblog

🔬In recognition of May being the Cystic Fibrosis Awareness Month, we would like to bring attention to the efforts behind this genetic disease and how the structural information of CFTR, a key protein in cystic fibrosis research, has brought insights into future drug development research. Read how it was done and how it was recreated utilizing the 3decision software: 👉https://bit.ly/4dJRRd2 #SBDD #cysticfibrosis #3decision #drugdiscovery #Discngine

Download the poster: "ASPYRE-Lung: Validation of a Simple, Fast, Robust and Novel Method for Multi-Variant Genomic Analysis of Actionable NSCLC Variants in FFPE Tissue" presented today at #AACR24 https://hubs.ly/Q02sqFTN0

See you at health.tech Munich; 5-6 June 2024 Please DM if you like to meet talking about sequencing, genetic diagnostics, biobanking, external sample storage, lab-on-chip systems. Looking forward to discuss topic such as rare diseases, stratgetic cooperations, investments, clinical trials. #ht24 #biotechnologie #diagnostics

Tackle the toughest of samples with Meridian SensiFAST™ Probe Direct SuperMix—a qPCR master mix engineered to overcome PCR inhibitors found in crude lysate or unprocessed blood, saliva, urine or tissue samples. Achieve quick and easy DNA extraction and amplification, boosting the success rate of your experiments. Product Highlights: • Robust: Proprietary buffer system neutralizes common inhibitors. • Specific: Antibody-mediated hot-start minimizes non-specific amplification. • Sensitive: Detects low abundance targets with precision. Enhance your qPCR workflows with SensiFAST™ Probe Direct SuperMix: https://ow.ly/sQlX50TAKAu #qPCR #MolecularBiology #Genomics #LifeSciences#directPCR

How can family medical history inform genetic testing strategies? Listen to this episode of “Answers From the Lab” as Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and genetic counselors Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC, discuss more. https://bit.ly/40WL0t2

You spoke, we listened! We have updated some of our EQA schemes based on your feedback, helping to save costs and time:  1. ⬇️ Reducing the maximum number of molecular pathology cases from 10 to 5.  2. 💻Using virtual cases to cover rare genotypes, whilst still providing cases with DNA for all EQA schemes to test the full analysis workflow.  3. 🔀 Piloting flexible EQA options, allowing you to participate in schemes that better align with your laboratory practices and diagnostic service scope.   4. 🛠️ Improving our website to make the purchase process faster, smoother, and with more visibility for all participants.  Read more about these new updates here: https://lnkd.in/eA4zi2dp  Subscribe to our newsletter to get the latest news on these changes and more to come! https://lnkd.in/e2UgGDKP  #emqn #eqa #qualityassurance #genetics  

More updates on 2025 developments coming in the next few days.

New Mimix PTEN Loss FFPE reference standard, cell line-derived to maintain genomic complexity. Explore the Mimix range http://ms.spr.ly/6041YHKO9